期刊
SCIENTIFIC REPORTS
卷 7, 期 -, 页码 -出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/s41598-017-03252-4
关键词
-
资金
- Ministry of Science and Technology, Taiwan [MOST 105-2314-B-038-081-MY3, MOST 105-2622-B-038-003-CC2, MOST 105-2632-B-038-001]
- National Health Research Institutes, Taiwan [NHRI-EX105-10238SC]
- Taipei Medical University [TMU100-AE1-B16]
- Comprehensive Cancer Center of Taipei Medical University/Health and Welfare Surcharge of Tobacco Products, Taiwan [MOHW106-TDU-B-212-144001]
Intestinal bacterial beta-glucuronidase (beta G) hydrolyzes glucuronidated metabolites to their toxic form in intestines, resulting in intestinal damage. The development of a method to inhibit beta G is thus important but has been limited by the difficulty of directly assessing enzyme activity in live animals. Here, we utilized a fluorescent probe, fluorescein di-beta-D-glucuronide (FDGlcU), to non-invasively image the intestinal bacterial beta G activity in nude mice. In vitro cell-based assays showed that the detection limit is 104 colony-forming units/well of beta G-expressing bacteria, and that 7.81 ng/mL of FDGlcU is enough to generate significant fluorescent signal. In whole-body optical images of nude mice, the maximum fluorescence signal for beta G activity in intestines was detected 3 hours after gavage with FDGlcU. Following pretreatment with a bacterial beta G inhibitor, the fluorescence signal was significantly reduced in abdomens and excised intestines images. For a 4-day antibiotic treatment to deplete intestinal bacteria, the FDGlcU-based images showed that the beta G activity was decreased by 8.5-fold on day 4 and then gradually increased after treatment stopped. The results suggested that FDGlcU-based imaging revealed the in vitro and in vivo activity of intestinal bacterial beta G, which would facilitate pharmacodynamic studies of specific bacterial beta G inhibitors in animal studies.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据